From April 1, 2022 to June 30, 2022, the company has repurchased 1,444,464 shares, representing 0.09% for CNY 12.56 million. With this, the company has completed the repurchase of 2,194,806 shares, representing 0.13% for CNY 20 million under the buyback announced on February 8, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.53 CNY | +3.14% |
|
-0.12% | -16.54% |
04-25 | Anhui Anke Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-28 | Anhui Anke Biotechnology Co., Ltd. Proposes Final Dividend for 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.54% | 1.96B | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- 300009 Stock
- News Anhui Anke Biotechnology (Group) Co., Ltd.
- Tranche Update on Anhui Anke Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2022.